R. Stockley (Birmingham, United Kingdom), J. Zielinski (Warsaw, Poland)
Role of HLA in genetic susceptibility to latent adenoviral infection and decreased lung function
I. Kasuga, J. C. Hogg, P. D. Pare, S. Hayashi, A. J. Sandford (Vancouver, Canada)
|  |
Upper and lower airway pathogens at exacerbation of COPD
J. R. Hurst, T. M. A. Wilkinson, W. R. Perera, G. C. Donaldson, J. A. Wedzicha (London, United Kingdom)
| |
The role of Moraxella catarrhalis in COPD
D. J. Powrie, T. M. Wilkinson, G. C. Donaldson, C. M. Dawson, J. A. Wedzicha (London, United Kingdom)
|  |
Local and systemic inflammation in acute viral exacerbations of COPD
G. Rohde, T. A. Duong Dinh, S. Jerzinowski, M. Kauth, A. Wiethege, I. Borg, U. Arinir, J. Kronsbein, G. Schultze-Werninghaus, T. T. Bauer (Bochum, Germany)
| |
Viral and bacterial etiology of severe COPD exacerbations: relationship with airway inflammation
A. Papi, C. Bellettato, F. Braccioni, M. Romagnoli, P. Casolari, G. Caramori, L. M. Fabbri, S. L. Johnston (Ferrara, Modena, Italy; London, United Kingdom)
| |
Molecular, metabolic and histological profiling reveal smoke worsens inflammation in a mouse model of viral COPD exacerbation
R. C. Gualano, J. E. Jones, M. J. Hansen, R. Vlahos, K. A. Duca, E. Fulton, G. P. Anderson (Melbourne, Australia; Blacksburg, United States Of America)
| |
Lung function and sputum neutrophil changes in an experimental model of virus-induced COPD exacerbations
P. Mallia, M. Contoli, M. Simon, V. Laza-Stanca, S. L. Johnston (London, United Kingdom)
| |
Prevalence of erythromycin resistance in lower airway bacterial isolates from patients with stable COPD
T. M. Wilkinson, W. R. Perera, J. R. Hurst, M. Wilks, G. C. Donaldson, J. A. Wedzicha (London, United Kingdom)
| |